Bausch Health Companies Inc. · Transaction Aug 27, 2020 · Filed Oct 7, 2020 · $1,001 to $15,000
TORONTO STOCK EXCHANGE · BHC
+0.66% · +$0.0400 · Vol 1.0M
Market closed · last close 4:00 PM ET · price as of 19:49:56 ET
Bausch Health Companies Inc
Pharmaceuticals
$6.08
Follow $BHC
One email when a member of Congress discloses a trade in it, with the official filing receipt linked.
Free. No account. Unsubscribe in one click.
Follow $BHC by emailVeridion Score
BETAHIGH CONF · 6 of 6 factors measuredStale score · Thu Oct 8 · completed session · 29h old · Scheduled each trading day · Markets closed · resumes Mon 9:30 ET · BHC
Methodologysnapshot unavailable for BHC. Cause unavailable.
BHC
Bausch Health Companies Inc
Stale score · Thu Oct 8 · completed session · 29h old · Scheduled each trading day · Markets closed · resumes Mon 9:30 ET
Upper range
Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.
Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
64/ 100
Veridion Score
Upper range · HIGH confidence · 6 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: HIGH · 6 of 6 factors measured · Stale score · Thu Oct 8 · completed session · 29h old · Scheduled each trading day · Markets closed · resumes Mon 9:30 ET
Veridion Score History · 90D
Loading score history
AI Analysis
SovereignWhy is BHC moving today?
Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About Bausch Health Companies Inc
PHARMACEUTICAL PREPARATIONSListed since
1994
Employees
20K
Country
CA
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum of its revenue from the Bausch + Lomb segment.
Key statistics
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Open
$6.05
Day high
$6.17
Day low
$6.01
Previous close
$6.04
52W high
$7.90
-23.04% from high
52W low
$4.43
48% of range
Market cap
$2.3B
P/E
14.39×
EPS
$-2.9592
Beta
0.73
Shares out
374M
Volume
1M
0.48× rel vol
Avg volume
2.2M
VWAP
$6.07
Price history computed in-house
1W
+4.83%
1M
+0.16%
3M
+27.20%
1Y
+0.50%
YTD
-12.52%
SMA 50 $6.21 · below
SMA 200 $5.76 · above
52W position 48%
BHC overview
Related filings and maps
Public disclosures
Congress activity in BHC
1 filers · 2 buys · 1 sells (0 labeled S (partial)) · Jan 6, 2020 to Aug 27, 2020 · House 3 / Senate 0
All available history · Latest 3 of 3 lines · Read 2026-10-10T03:47:55.649Z
Official filing ↗
Bausch Health Companies Inc. · Transaction Feb 24, 2020 · Filed Apr 28, 2020 · $1,001 to $15,000
Bausch Health Companies Inc. · Transaction Jan 6, 2020 · Filed Feb 25, 2020 · $1,001 to $15,000
Federal contracts
BHC contract awards, year to date.
Public federal awards linked to this ticker.
Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for BHC in this window.
Lobbying spend
BHC lobbying filings, year to date.
Registered lobbying filings matched to Bausch Health Companies Inc.
Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for BHC in this window.
Analyst ratings
Sovereign unlock shows live analyst consensus for BHC.
Options
Options data is temporarily unavailable. Changing your plan will not restore the upstream feed.